Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice

Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice

Bo Ding,1 Lee Kallenbach,2 Lukas Slipski,2 Alan Wilk,2 Dan O’Brien,2 Deniz Guranlioglu3 1AstraZeneca, Gothenburg, Sweden; 2Practice Fusion, San Francisco, CA, USA; 3AstraZeneca, Cambridge, UKCorrespondence: Bo DingAstraZeneca, Pepparedsleden 1, Gothenburg SE 431 83, Mölndal, Swede...

Full description

Bibliographic Details
Main Authors: Ding B, Kallenbach L, Slipski L, Wilk A, O'Brien D, Guranlioglu D
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:International Journal of COPD
Subjects:
muscarinic antagonist
β2-agonist
demographic characteristics
disease characteristics
cost
Online Access:https://www.dovepress.com/patient-characteristics-and-healthcare-resource-utilization-among-pati-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/patient-characteristics-and-healthcare-resource-utilization-among-pati-peer-reviewed-article-COPD

Similar Items